Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
5 "Persistent"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Original Article
THESIS (Treatment of Hypothyroidism in Europe by Specialists: An International Survey) Questionnaire Survey of Medical Thyroid Specialists in Korea on the Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients
Jee Hee Yoon, Dong Yeob Shin, Hee Kyung Kim, Roberto Attanasio, Enrico Papini, Petros Perros, Endre V. Nagy, Laszlo Hegedüs, Sun Wook Kim, Ho-Cheol Kang
Received December 18, 2025  Accepted February 27, 2026  Published online July 8, 2026  
DOI: https://doi.org/10.3803/EnM.2025.2868    [Epub ahead of print]
  • 742 View
  • 42 Download
AbstractAbstract PDFPubReader   ePub   
Background
Recent surveys have highlighted substantial variability in the management of hypothyroidism that is associated with physician demographic and geo-economic characteristics. This study aimed to assess preferences for thyroid hormone therapy among medical thyroid specialists in Korea.
Methods
An online survey was conducted using the Treatment of Hypothyroidism in Europe by Specialists: An International Survey (THESIS) questionnaire. Participants were medical thyroid specialists who were members of the Korean Thyroid Association (KTA).
Results
Among the 349 regular members of the KTA who were physicians, 53 (15.2%) completed the survey. All respondents reported prescribing levothyroxine (LT4) as the initial treatment of choice for hypothyroidism. For patients with biochemical euthyroidism, 64.2% of respondents indicated that treatment was unnecessary; however, several conditions were cited as potential indications for thyroid hormone use (multiple responses were allowed), including female infertility with elevated thyroid antibody levels (30.2%), enlarging simple goiter (17.0%), and severe hypercholesterolemia as adjunctive therapy (9.4%). Although 24.5% of respondents reported avoiding LT4+liothyronine (LT3) therapy because of low-quality evidence, 62.3% indicated that they would consider it for symptomatic patients receiving LT4 monotherapy with normal thyroid-stimulating hormone levels.
Conclusion
Korean thyroid specialists generally adhere to current clinical guidelines, favoring LT4 as the standard treatment for hypothyroidism. However, there is considerable willingness to use LT4+LT3 combination therapy and to prescribe thyroid hormones for certain non-thyroid conditions. Ongoing educational efforts are needed to improve understanding that many persistent symptoms despite biochemical euthyroidism are influenced by psychosocial factors and to facilitate consistent implementation of evidencebased, guideline-aligned clinical practice.
Close layer
Review Article
Thyroid
T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
Wilmar M. Wiersinga
Endocrinol Metab. 2021;36(5):938-951.   Published online September 30, 2021
DOI: https://doi.org/10.3803/EnM.2021.501
  • 35,142 View
  • 501 Download
  • 21 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   ePub   
Thyroxine (T4)+triiodothyronine (T3) combination therapy can be considered in case of persistent symptoms despite normal serum thyroid stimulating hormone in levothyroxine (LT4)-treated hypothyroid patients. Combination therapy has gained popularity in the last two decades, especially in countries with a relatively high gross domestic product. The prevalence of persistent symptoms has also increased; most frequent are complaints about energy levels and fatigue (80% to 90%), weight management (70% to 75%), memory (60% to 80%), and mood (40% to 50%). Pathophysiological explanations for persistent problems are unrealistic patient expectations, comorbidities, somatic symptoms, related disorders (Diagnostic and Statistical Manual of Mental Disorders [DSM-5]), autoimmune neuroinflammation, and low tissue T3. There is fair circumstantial evidence for the latter cause (tissue and specifically brain T3 content is normalized by T4+T3, not by T4 alone), but the other causes are viewed as more relevant in current practice. This might be related to the ‘hype’ that has emerged surrounding T4+T3 therapy. Although more and better-designed trials are needed to validate the efficacy of T4+T3 combination, the management of persistent symptoms should also be directed towards alternative causes. Improving the doctor-patient relationship and including more and better information is crucial. For example, dissatisfaction with the outcomes of T4 treatment for subclinical hypothyroidism can be anticipated as recent trials have demonstrated that LT4 is hardly effective in improving symptoms associated with subclinical hypothyroidism.

Citations

Citations to this article as recorded by  
  • Hemodialysis Tends to Improve Thyroid Function by Restoring Hormone Levels in ESRD Patients Compared to Non-Dialysis Kidney Disease Patients: A Case–Control Study
    Hasibul Islam, Shahad Saif Khandker, Anwara Khatun, Ehsan Suez, Alif Hasan Pranto, Dewan Zubaer Islam, Rahima Begum, Md. Nizam Uddin, Md. Ashraful Hasan, Md. Shah Alam, A. N. M. Mamun-Or-Rashid
    Diseases.2026; 14(4): 128.     CrossRef
  • Developing a machine learning-based predictive model for levothyroxine dosage estimation in hypothyroid patients: a retrospective study
    Tran Thi Ngan, Dang Huong Tra, Ngo Thi Quynh Mai, Hoang Van Dung, Nguyen Van Khai, Pham Van Linh, Nguyen Thi Thu Phuong
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Thyroid hormone use in clinical practice by Israeli endocrinologists: a THESIS* questionnaire survey
    Liat Sasson, Keren Kaminer, Chagit Adler Cohen, Laszlo Hegedüs, Roberto Negro, Endre V. Nagy, Enrico Papini, Petros Perros, Roberto Attanasio, Eyal Robenshtok
    Thyroid Research.2025;[Epub]     CrossRef
  • Advances in hypothyroidism management: rethinking therapy beyond levothyroxine
    R Ditshego, J Pick, KN Ncube
    SA Pharmaceutical Journal.2025; 92(4): 50.     CrossRef
  • Association of DIO2 and MCT10 Polymorphisms With Persistent Symptoms in LT4-Treated Patients in the UK Biobank
    Christian Zinck Jensen, Jonas Lynggaard Isaksen, Gustav Ahlberg, Morten Salling Olesen, Birte Nygaard, Christina Ellervik, Jørgen Kim Kanters
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e613.     CrossRef
  • Quality of life, daily functioning, and symptoms in hypothyroid patients on thyroid replacement therapy: A Dutch survey
    Ellen Molewijk, Eric Fliers, Koen Dreijerink, Ad van Dooren, Rob Heerdink
    Journal of Clinical & Translational Endocrinology.2024; 35: 100330.     CrossRef
  • Cardiovascular mechanisms of thyroid hormones and heart failure: Current knowledge and perspectives
    Viktor Čulić
    World Journal of Cardiology.2024; 16(5): 226.     CrossRef
  • Use of thyroid hormones in hypothyroid and euthyroid patients: A survey of members of the Endocrine Society of Australia
    Nicole Lafontaine, Suzanne J. Brown, Petros Perros, Enrico Papini, Endre V. Nagy, Roberto Attanasio, Laszlo Hegedüs, John P. Walsh
    Clinical Endocrinology.2024; 100(5): 477.     CrossRef
  • Triiodothyronine levels in athyreotic pediatric patients during levothyroxine therapy
    Julia Baran, Amber Isaza, Mya Bojarsky, Lama Alzoebie, Minkeun Song, Stephen Halada, Lindsay Sisko, Stephanie Gonzales, Sogol Mostoufi-Moab, Andrew J. Bauer
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Posttreatment symptoms in hypothyroidism and correlations with thyroid-stimulating hormone and free triiodothyronine and free thyroxine: A ThyPRO-based follow-up study
    Ashika Davis, Jyothi Mariam Idiculla
    Thyroid Research and Practice.2024; 20(2): 64.     CrossRef
  • A review of the safety of triiodothyronine in combination with levothyroxine for the management of hypothyroidism
    Ulrike Gottwald-Hostalek, Yorki Tayrouz
    Current Medical Research and Opinion.2024; 40(12): 2109.     CrossRef
  • Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A THESIS questionnaire survey of members of the Irish Endocrine Society
    Mohamad Mustafa, Elsheikh Ali, Anne McGowan, Laura McCabe, Laszlo Hegedüs, Roberto Attanasio, Endre V. Nagy, Enrico Papini, Petros Perros, Carla Moran
    Irish Journal of Medical Science (1971 -).2023; 192(5): 2179.     CrossRef
  • Levothyroxine: Conventional and Novel Drug Delivery Formulations
    Hanqing Liu, Wei Li, Wen Zhang, Shengrong Sun, Chuang Chen
    Endocrine Reviews.2023; 44(3): 393.     CrossRef
  • Re: “Exploring the Genetic Link Between Thyroid Dysfunction and Common Psychiatric Disorders: A Specific Hormonal or a General Autoimmune Comorbidity” by Soheili-Nezhad et al.
    Christiaan F. Mooij, A.S. Paul van Trotsenburg
    Thyroid®.2023; 33(8): 999.     CrossRef
  • Circulating thyroid hormones and clinical parameters of heart failure in men
    Iva Turić, Ivan Velat, Željko Bušić, Viktor Čulić
    Scientific Reports.2023;[Epub]     CrossRef
  • Evaluation of cortical and trabecular bone structure of the mandible in patients using L-Thyroxine
    Melike Gulec, Melek Tassoker, Mediha Erturk
    BMC Oral Health.2023;[Epub]     CrossRef
  • The Impact of Hypothyroidism on Satisfaction with Care and Treatment and Everyday Living: Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey
    Petros Perros, Laszlo Hegedüs, Endre Vezekenyi Nagy, Enrico Papini, Harriet Alexandra Hay, Juan Abad-Madroñero, Amy Johanna Tallett, Megan Bilas, Peter Lakwijk, Alan J. Poots
    Thyroid.2022;[Epub]     CrossRef
Close layer
Original Article
Clinical Study
High Serum-Induced AhRL Is Associated with Prevalent Metabolic Syndrome and Future Impairment of Glucose Tolerance in the Elderly
Youngmi Kim Pak, Hoon Sung Choi, Wook Ha Park, Suyeol Im, P. Monica Lind, Lars Lind, Hong Kyu Lee
Endocrinol Metab. 2021;36(2):436-446.   Published online April 19, 2021
DOI: https://doi.org/10.3803/EnM.2020.883
  • 7,992 View
  • 122 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
High circulating levels of dioxins and dioxin-like chemicals, acting via the aryl hydrocarbon receptor (AhR), have previously been linked to diabetes. We now investigated whether the serum AhR ligands (AhRL) were higher in subjects with metabolic syndrome (MetS) and in subjects who had developed a worsened glucose tolerance over time.
Methods
Serum AhRL at baseline was measured by a cell-based AhRL activity assay in 70-year-old subjects (n=911) in the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. The main outcome measures were prevalent MetS and worsening of glucose tolerance over 5 years of follow-up.
Results
AhRL was significantly elevated in subjects with prevalent MetS as compared to those without MetS, following adjustment for sex, smoking, exercise habits, alcohol intake and educational level (P=0.009). AhRL at baseline was higher in subjects who developed impaired fasting glucose or diabetes at age 75 years than in those who remained normoglycemic (P=0.0081). The odds ratio (OR) of AhRL for worsening glucose tolerance over 5 years was 1.43 (95% confidence interval [CI], 1.13 to 1.81; P=0.003, continuous variables) and 2.81 (95% CI, 1.31 to 6.02; P=0.008, in the highest quartile) adjusted for sex, life style factors, body mass index, and glucose.
Conclusion
These findings support a large body of epidemiologic evidence that exposure to AhR transactivating substances, such as dioxins and dioxin-like chemicals, might be involved in the pathogenesis of MetS and diabetes development. Measurement of serum AhRL in humans can be a useful tool in predicting the onset of metabolic disorders.

Citations

Citations to this article as recorded by  
  • Correlation between environmental pollutant exposure and cardiopulmonary health by serum biomarker analysis in the Swedish elderly population
    Youngmi Kim Pak, Suyeol Im, Hoon Sung Choi, Lars Lind, Monica Lind, Hong Kyu Lee
    International Journal of Environmental Health Research.2025; 35(5): 1156.     CrossRef
  • Hepatic AhR Activation by TCDD Induces Obesity and Steatosis via Hepatic Plasminogen Activator Inhibitor-1 (PAI-1)
    Seung Jun Oh, Suyeol Im, Sora Kang, Aden Geonhee Lee, Byung Cheol Lee, Youngmi Kim Pak
    International Journal of Molecular Sciences.2025; 26(17): 8452.     CrossRef
  • Association between polychlorinated biphenyl (PCB) and dioxin with metabolic syndrome (METS): a systematic review and meta-analysis
    Mohd Danial Mohd Efendy Goon, Sarah Zulkifli, Siti Suhana Abdullah Soheimi, Sharaniza Ab. Rahim, Normala Abd Latip, Norbaya Hashim, Nirmala Devi Kerisnan, Nasehir Khan E. M. Yahaya, Alias Mohamed, Siti Hamimah Sheikh Abdul Kadir
    Scientific Reports.2024;[Epub]     CrossRef
  • Relationships among Dioxin-like Mitochondria Inhibitor Substances (MIS)-Mediated Mitochondria Dysfunction, Obesity, and Lung Function in a Korean Cohort
    Hoonsung Choi, Kyungho Ha, Jin Taek Kim, Min Kyong Moon, Hyojee Joung, Hong Kyu Lee, Youngmi Kim Pak
    Toxics.2024; 12(10): 735.     CrossRef
  • An Interactive Online App for Predicting Diabetes via Machine Learning from Environment-Polluting Chemical Exposure Data
    Rosy Oh, Hong Kyu Lee, Youngmi Kim Pak, Man-Suk Oh
    International Journal of Environmental Research and Public Health.2022; 19(10): 5800.     CrossRef
  • A Novel Aryl Hydrocarbon Receptor Antagonist HBU651 Ameliorates Peripheral and Hypothalamic Inflammation in High-Fat Diet-Induced Obese Mice
    Sora Kang, Aden Geonhee Lee, Suyeol Im, Seung Jun Oh, Hye Ji Yoon, Jeong Ho Park, Youngmi Kim Pak
    International Journal of Molecular Sciences.2022; 23(23): 14871.     CrossRef
Close layer
Review Article
Miscellaneous
Evidence of the Possible Harm of Endocrine-Disrupting Chemicals in Humans: Ongoing Debates and Key Issues
Duk-Hee Lee
Endocrinol Metab. 2018;33(1):44-52.   Published online March 21, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.44
  • 20,451 View
  • 195 Download
  • 52 Web of Science
  • 56 Crossref
AbstractAbstract PDFPubReader   ePub   

Evidence has emerged that endocrine-disrupting chemicals (EDCs) can produce adverse effects, even at low doses that are assumed safe. However, systemic reviews and meta-analyses focusing on human studies, especially of EDCs with short half-lives, have demonstrated inconsistent results. Epidemiological studies have insuperable methodological limitations, including the unpredictable net effects of mixtures, non-monotonic dose-response relationships, the non-existence of unexposed groups, and the low reliability of exposure assessment. Thus, despite increases in EDC-linked diseases, traditional epidemiological studies based on individual measurements of EDCs in bio-specimens may fail to provide consistent results. The exposome has been suggested as a promising approach to address the uncertainties surrounding human studies, but it is never free from these methodological issues. Although exposure to EDCs during critical developmental periods is a major concern, continuous exposure to EDCs during non-critical periods is also harmful. Indeed, the evolutionary aspects of epigenetic programming triggered by EDCs during development should be considered because it is a key mechanism for developmental plasticity. Presently, living without EDCs is impossible due to their omnipresence. Importantly, there are lifestyles which can increase the excretion of EDCs or mitigate their harmful effects through the activation of mitohormesis or xenohormesis. Effectiveness of lifestyle interventions should be evaluated as practical ways against EDCs in the real world.

Citations

Citations to this article as recorded by  
  • Consequences and Functional Alterations of Endocrine Disruptors on Women's Health
    Diksha Mishra, Rohit Singh, Nandakumar U.P., Rajesh Pradhan, Sharad Chand
    Current Women s Health Reviews.2026;[Epub]     CrossRef
  • Organic micropollutants in the environment: A literature review
    Ankita Chandel, Harleen Kaur, Ashish Sharma, Vinod Kumar
    Journal of Geochemical Exploration.2026; 284: 107997.     CrossRef
  • Microplastics found in Weddell seal placenta in Antarctica, potential threatening marine ecosystem health
    Xing Miao, Conghui Peng, Renxin Zhang, Baohong Chen, Zongzheng Chen, Hui Lin, Tingting Fu, Yuan Li, Longshan Lin
    Journal of Hazardous Materials.2026; 504: 141378.     CrossRef
  • Cadmium exposure and thyroid hormone disruption: a systematic review and meta-analysis
    Seung Min Chung, Min Cheol Chang
    Reviews on Environmental Health.2025; 40(1): 37.     CrossRef
  • Microplastics pollution in Australia: Sources, impacts, and mitigation strategies
    Rumana Hossain, Anirban Ghose, Veena Sahajwalla
    Case Studies in Chemical and Environmental Engineering.2025; 11: 101036.     CrossRef
  • A review on optimizing photocatalytic performance for effective removal of emerging pollutants: Approaches and applications
    R. Kamalesh, A. Saravanan, Y.P. Ragini, A.S. Vickram
    Journal of Water Process Engineering.2025; 69: 106883.     CrossRef
  • Are (bio)electrochemical techniques sustainable solutions to combat micro- and nano-plastic pollution?
    Almeenu Rasheed, Yasser Bashir, Sovik Das
    Current Opinion in Chemical Engineering.2025; 47: 101091.     CrossRef
  • Premature thelarche and pesticide exposure: A case-control study in an intensive agricultural area
    Lucia Coppola, Enrica Fabbrizi, Giovanni Angelozzi, Chiara Laura Battistelli, Alice Catena, Lorella Ciferri, Annamaria Iannetta, Sabrina Tait, Monia Perugini, Cinzia La Rocca
    International Journal of Hygiene and Environmental Health.2025; 264: 114524.     CrossRef
  • Prenatal exposure to Bisphenol-A as a risk factor for infant neurodevelopment
    Ivan Hazel Bello-Cortes, Jose Antonio García-García, Manuel Gutiérrez-Aguilar, Daniela Araiza-Olivera, Celia Sánchez-Pérez, Gabriela García-Cerón, Sofia Morán-Ramos, Hugo Tovar, Andrea Bonilla-Brunner, Roeb García-Arrazola
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Joint and interactive effects of metal mixtures on liver damage: Epidemiological evidence from repeated-measures study
    Guohuan Yin, Shuanzheng Zhao, Meiduo Zhao, Jing Xu, Xiaoyu Ge, Jingtao Wu, Yifan Zhou, Xiaolin Liu, Lanping Wei, Qun Xu
    Ecotoxicology and Environmental Safety.2024; 274: 116178.     CrossRef
  • Thyroid under siege: Unravelling the toxic impact of real-life metal mixture exposures in Wistar rats
    Đurđica Marić, Katarina Baralić, Dragana Vukelić, Ivan Milošević, Anja Nikolić, Biljana Antonijević, Danijela Đukić-Ćosić, Zorica Bulat, Michael Aschner, Aleksandra Buha Djordjevic
    Chemosphere.2024; 360: 142441.     CrossRef
  • Mitigation Strategies of Emerging Pollutants from Cosmetic Industry Effluent: A Review
    Bishal Das, Sayanee Sarkar, Sourav Paul, Ayesha Zafar, Deepika Biswas, Jigisha Roy Panda, Tamalika Chakraborty
    European Journal of Theoretical and Applied Sciences.2024; 2(3): 886.     CrossRef
  • Endocrine-Disrupting Compounds in Urban Soils of Malaysia: Occurrence, Contamination, and Impacts on Health and the Environment
    Michael Lie, Joseph Kasongo, Elias Mtui, Rubiyatno, Jovale Vincent Tongco
    Tropical Aquatic and Soil Pollution.2024;[Epub]     CrossRef
  • Reconsidering “low‐dose”—Impacts of oral estrogen exposure during preimplantation embryo development
    Meret Schmidhauser, Anna‐Katharina Hankele, Susanne E. Ulbrich
    Molecular Reproduction and Development.2023; 90(7): 445.     CrossRef
  • Simultaneous estimation of methyl paraben, propyl paraben, and Bisphenol A in the plasma of Indian pregnant women using liquid chromatography–tandem mass spectrometry
    Rajesh Pradhan, Diksha Mishra, Sunil Kumar Dubey, Rajesh Khadgawat, Garima Kachhawa, Tarang Gupta, Rajeev Taliyan
    SEPARATION SCIENCE PLUS.2023;[Epub]     CrossRef
  • Influences of key factors on river water quality in urban and rural areas: A review
    Nguyen Tuan Anh, Le Duy Can, Nguyen Thi Nhan, Britta Schmalz, Tran Le Luu
    Case Studies in Chemical and Environmental Engineering.2023; 8: 100424.     CrossRef
  • Human health risk assessment for consumption of microplastics and plasticizing substances through marine species
    Virginia Montero, Yarenis Chinchilla, Luis Gómez, Adrián Flores, Alejandro Medaglia, Rossy Guillén, Ernesto Montero
    Environmental Research.2023; 237: 116843.     CrossRef
  • Effects of postnatal exposure to phthalate, bisphenol a, triclosan, parabens, and per- and poly-fluoroalkyl substances on maternal postpartum depression and infant neurodevelopment: a korean mother-infant pair cohort study
    Ju Hee Kim, Nalae Moon, Eunsun Ji, Hyo-Bang Moon
    Environmental Science and Pollution Research.2023; 30(42): 96384.     CrossRef
  • Systematic review of prenatal exposure to endocrine disrupting chemicals and autism spectrum disorder in offspring
    Salvador Marí-Bauset, Isabel Peraita-Costa, Carolina Donat-Vargas, Agustín Llopis-González, Amelia Marí-Sanchis, Juan Llopis-Morales, María Morales Suárez-Varela
    Autism.2022; 26(1): 6.     CrossRef
  • Elucidation of xenoestrogen metabolism by non-targeted, stable isotope-assisted mass spectrometry in breast cancer cells
    Mira Flasch, Christoph Bueschl, Giorgia Del Favero, Gerhard Adam, Rainer Schuhmacher, Doris Marko, Benedikt Warth
    Environment International.2022; 158: 106940.     CrossRef
  • Fetoplacental vasculature as a model to study human cardiovascular endocrine disruption
    Margarida Lorigo, Elisa Cairrao
    Molecular Aspects of Medicine.2022; 87: 101054.     CrossRef
  • UV-B Filter Octylmethoxycinnamate Is a Modulator of the Serotonin and Histamine Receptors in Human Umbilical Arteries
    Margarida Lorigo, Carla Quintaneiro, Luiza Breitenfeld, Elisa Cairrao
    Biomedicines.2022; 10(5): 1054.     CrossRef
  • Microbiota analysis for risk assessment: evaluation of hazardous dietary substances and its potential role on the gut microbiome variability and dysbiosis
    Klara Cerk, Margarita Aguilera‐Gómez
    EFSA Journal.2022;[Epub]     CrossRef
  • Human adrenocortical carcinoma cell line (NCI-H295R): An in vitro screening model for the assessment of endocrine disruptors’ actions on steroidogenesis with an emphasis on cell ultrastructural features
    Hana Duranova, Veronika Fialkova, Veronika Valkova, Jana Bilcikova, Lucia Olexikova, Norbert Lukac, Peter Massanyi, Zuzana Knazicka
    Acta Histochemica.2022; 124(5): 151912.     CrossRef
  • Endocrine Disrupting Compounds (Nonylphenol and Bisphenol A)–Sources, Harmfulness and Laccase-Assisted Degradation in the Aquatic Environment
    Agnieszka Gałązka, Urszula Jankiewicz
    Microorganisms.2022; 10(11): 2236.     CrossRef
  • Subacute exposure to lead promotes disruption in the thyroid gland function in male and female rats
    Niedson Correia de Lima Junior, Juliana Franco Camilo, Pâmella Rodrigues do Carmo, Marcelle Novaes de Andrade, Bernardo Ferreira Braz, Ricardo Erthal Santelli, Lycia de Brito Gitirana, Andrea Claudia Freitas Ferreira, Denise Pires de Carvalho, Leandro Mir
    Environmental Pollution.2021; 274: 115889.     CrossRef
  • Plasticenta: First evidence of microplastics in human placenta
    Antonio Ragusa, Alessandro Svelato, Criselda Santacroce, Piera Catalano, Valentina Notarstefano, Oliana Carnevali, Fabrizio Papa, Mauro Ciro Antonio Rongioletti, Federico Baiocco, Simonetta Draghi, Elisabetta D'Amore, Denise Rinaldo, Maria Matta, Elisabet
    Environment International.2021; 146: 106274.     CrossRef
  • Impact of endocrine-disrupting chemicals on steroidogenesis and consequences on testicular function
    Casandra Walker, Samuel Garza, Vassilios Papadopoulos, Martine Culty
    Molecular and Cellular Endocrinology.2021; 527: 111215.     CrossRef
  • Best Achievements in Translational and Basic Thyroidology in 2020
    Sun Wook Cho, Young Joo Park
    Endocrinology and Metabolism.2021; 36(1): 36.     CrossRef
  • Endocrine disrupting chemicals in the pathogenesis of hypospadias; developmental and toxicological perspectives
    Deidre M. Mattiske, Andrew J. Pask
    Current Research in Toxicology.2021; 2: 179.     CrossRef
  • Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?
    Pheruza Tarapore, Bin Ouyang
    International Journal of Environmental Research and Public Health.2021; 18(7): 3794.     CrossRef
  • Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
    Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez
    International Journal of Molecular Sciences.2021; 22(9): 4807.     CrossRef
  • Microplastics in aquatic environment: Challenges and perspectives
    Aashlesha Chekkala Vivekanand, Sanjeeb Mohapatra, Vinay Kumar Tyagi
    Chemosphere.2021; 282: 131151.     CrossRef
  • A Review on Emerging Pollutants in the Water Environment: Existences, Health Effects and Treatment Processes
    Nor Zaiha Arman, Salmiati Salmiati, Azmi Aris, Mohd Razman Salim, Tasnia Hassan Nazifa, Mimi Suliza Muhamad, Marpongahtun Marpongahtun
    Water.2021; 13(22): 3258.     CrossRef
  • Effects of different influent C/N ratios on microbial community and selected estrogens removal in a sequencing batch reactor
    Bingchen Zhao, Jie Lan, Dong Chen, Linlin Li
    Desalination and Water Treatment.2021; 223: 128.     CrossRef
  • Urban-level environmental factors related to pediatric asthma
    Inês Paciência, João Cavaleiro Rufo
    Porto Biomedical Journal.2020; 5(1): e57.     CrossRef
  • Mechanisms of Testicular Disruption from Exposure to Bisphenol A and Phtalates
    Francesco Pallotti, Marianna Pelloni, Daniele Gianfrilli, Andrea Lenzi, Francesco Lombardo, Donatella Paoli
    Journal of Clinical Medicine.2020; 9(2): 471.     CrossRef
  • Developmental instability is associated with estrogenic endocrine disruption in the Chilean native fish species, Trichomycterus areolatus
    Angéline Bertin, Gautier Damiens, Daniela Castillo, Ricardo Figueroa, Christophe Minier, Nicolas Gouin
    Science of The Total Environment.2020; 714: 136638.     CrossRef
  • Tyrosinase nanocapsule based nano-biosensor for ultrasensitive and rapid detection of bisphenol A with excellent stability in different application scenarios
    Lingxia Wu, Xianbo Lu, Kai Niu, Dhanjai, Jiping Chen
    Biosensors and Bioelectronics.2020; 165: 112407.     CrossRef
  • The sex-specific effects of blood lead, mercury, and cadmium levels on hepatic steatosis and fibrosis: Korean nationwide cross-sectional study
    Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Trace Elements in Medicine and Biology.2020; 62: 126601.     CrossRef
  • Diet: A Source of Endocrine Disruptors
    Hina Rashid, Saad S. Alqahtani, Saeed Alshahrani
    Endocrine, Metabolic & Immune Disorders - Drug Targets.2020; 20(5): 633.     CrossRef
  • Aryl-hydrocarbon receptor binding and the incidence of type 2 diabetes: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)
    Bruce B. Duncan, Cristina D. Castilhos, Paula A. Bracco, Maria I. Schmidt, Sora Kang, Suyeol Im, Hong-Kyu Lee, Álvaro Vigo, Youngmi K. Pak
    Environmental Health.2020;[Epub]     CrossRef
  • Endocrinology and Metabolism Has Been Indexed in MEDLINE: A Major Achievement
    Won-Young Lee
    Endocrinology and Metabolism.2019; 34(2): 138.     CrossRef
  • Endocrine-disrupting chemicals: Effects on neuroendocrine systems and the neurobiology of social behavior
    Andrea C. Gore, Krittika Krishnan, Michael P. Reilly
    Hormones and Behavior.2019; 111: 7.     CrossRef
  • Removal of Pharmaceutical Contaminants in Wastewater Using Nanomaterials: A Comprehensive Review
    Anjali Chauhan, Devendra Sillu, Shekhar Agnihotri
    Current Drug Metabolism.2019; 20(6): 483.     CrossRef
  • Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
    Olga Papalou, Eleni A. Kandaraki, George Papadakis, Evanthia Diamanti-Kandarakis
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
  • Adverse Effect of Nonylphenol on the Reproductive System in F2 Male Mice : A Qualitative Change?
    Yong-Bin Kim, Yong-Pil Cheon, Donchan Choi, Sung-Ho Lee
    Development & Reproduction.2019; 23(3): 255.     CrossRef
  • Association of serum levels of p,p’- Dichlorodiphenyldichloroethylene (DDE) with type 2 diabetes in African American and Caucasian adult men from agricultural (Delta) and non-agricultural (non-Delta) regions of Mississippi
    Edward C. Meek, Dana Dale Jones, J. Allen Crow, Robert W. Wills, William H. Cooke, Janice E. Chambers
    Journal of Toxicology and Environmental Health, Part A.2019; 82(6): 387.     CrossRef
  • UV-B Filter Octylmethoxycinnamate Induces Vasorelaxation by Ca2+ Channel Inhibition and Guanylyl Cyclase Activation in Human Umbilical Arteries
    Margarida Lorigo, Carla Quintaneiro, Manuel C. Lemos, José Martinez-de-Oliveira, Luiza Breitenfeld, Elisa Cairrao
    International Journal of Molecular Sciences.2019; 20(6): 1376.     CrossRef
  • Transgenerational effects of BPA on female reproduction
    Stefania Santangeli, Claudia Consales, Francesca Pacchierotti, Hamid R. Habibi, Oliana Carnevali
    Science of The Total Environment.2019; 685: 1294.     CrossRef
  • Exposure to polybrominated biphenyl and stochastic epigenetic mutations: application of a novel epigenetic approach to environmental exposure in the Michigan polybrominated biphenyl registry
    Sarah W. Curtis, Dawayland O. Cobb, Varun Kilaru, Metrecia L. Terrell, M. Elizabeth Marder, Dana Boyd Barr, Carmen J. Marsit, Michele Marcus, Karen N. Conneely, Alicia K. Smith
    Epigenetics.2019; 14(10): 1003.     CrossRef
  • Determining the endocrine disruption potential of industrial chemicals using an integrative approach: Public databases, in vitro exposure, and modeling receptor interactions
    Olubusayo Alofe, Edwina Kisanga, Salmaan H. Inayat-Hussain, Masao Fukumura, Rolando Garcia-Milian, Lalith Perera, Vasilis Vasiliou, Shannon Whirledge
    Environment International.2019; 131: 104969.     CrossRef
  • 4-Nonylphenol-Enhanced EZH2 and RNF2 Expression, H3K27me3 and H2AK119ub1 Marks Resulting in Silencing of p21 CDKN1A  
    Krishna Ghosh, Biji Chatterjee, Uma Maheswari, Mariyam Athifa, Santosh R Kanade
    Epigenomics.2019; 11(8): 899.     CrossRef
  • Sex-specific effects of blood cadmium on thyroid hormones and thyroid function status: Korean nationwide cross-sectional study
    Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Trace Elements in Medicine and Biology.2019; 53: 55.     CrossRef
  • Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
    Laura Escrivá, Annika Hanberg, Johanna Zilliacus, Anna Beronius
    EFSA Journal.2019;[Epub]     CrossRef
  • Comparative assessment of endocrine disrupting compounds removal in heterotrophic and enriched nitrifying biomass
    Elissavet Kassotaki, Maite Pijuan, Ignasi Rodriguez-Roda, Gianluigi Buttiglieri
    Chemosphere.2019; 217: 659.     CrossRef
Close layer
Original Article
Diabetes, Obesity and Metabolism
The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study
Yu Hyun Kwon, Seul-Ki Kim, Jung Hwan Cho, Hyemi Kwon, Se Eun Park, Hyung-Geun Oh, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee
Endocrinol Metab. 2018;33(1):55-61.   Published online January 30, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.1.55
  • 8,531 View
  • 72 Download
  • 14 Web of Science
  • 14 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Hypertriglyceridemia is known to have an association with increased risks of insulin resistance and diabetes. The aim of this study was to investigate the risk of diabetes mellitus, according to changes in the concentrations of triglycerides, over time.

Methods

A total of 15,932 non-diabetic participants (mean age 43.2 years, 68% men) who attended five consecutive annual health check-ups at Kangbuk Samsung Hospital, between January 2010 and December 2014, were recruited. Participants were classified according to their triglyceride concentrations; normal (<150 mg/dL) and abnormal (≥150 mg/dL). According to the triglyceride levels in 2010 and 2012, subjects were divided into four groups: normal-normal, normal-abnormal, abnormal-normal, and abnormal-abnormal. The risk for incident diabetes was assessed in 2014.

Results

Among the total subjects, 67.5% belonged to the normal-normal group, 8.6% to the normal-abnormal group, 9.4% to the abnormal-normal group, and 14.5% to the abnormal-abnormal group. A total of 234 subjects (1.5%) were newly diagnosed with diabetes, between 2010 and 2014. Over 4 years, 1%, 1.5%, 2.1%, and 3.0% of the subjects developed diabetes in the normal-normal, normal-abnormal, abnormal-normal, and abnormal-abnormal groups, respectively. When the risk for incident diabetes was analyzed in the groups, after adjusting the confounding variables, a 1.58-fold increase in the risk of diabetes (95% confidence interval [CI], 1.10 to 2.26) was observed in the participants with persistent hypertriglyceridemia (abnormal-abnormal group). This was attenuated by further adjustments for body mass index (BMI) (hazard ratio, 1.25; 95% CI, 0.86 to 1.80).

Conclusion

In this large study population, persistent hypertriglyceridemia, over a period of 2 years, was significantly associated with the risk of incident diabetes, which was attenuated after adjustment for BMI.

Citations

Citations to this article as recorded by  
  • Cumulative exposure to hypertriglyceridemia and risk of type 2 diabetes in young adults
    Min-Kyung Lee, Kyungdo Han, Bongsung Kim, Jong-Dai Kim, Moon Jung Kim, Byungpyo Kim, Jung Heo, Jiyeon Ahn, Seo-Young Sohn, Jae-Hyuk Lee
    Diabetes Research and Clinical Practice.2024; 208: 111109.     CrossRef
  • Usefulness of SPISE Index for Screening and Detection of Early Stages of Insulin Resistance among Chilean Young Adults
    Isabel Pereyra González, Sandra Lopez-Arana
    Annals of Nutrition and Metabolism.2023; 79(4): 372.     CrossRef
  • Lipid variability in patients with diabetes mellitus
    Jeongmin Lee, Seung-Hwan Lee
    Cardiovascular Prevention and Pharmacotherapy.2023; 5(4): 126.     CrossRef
  • Sesamin: A Promising Therapeutic Agent for Ameliorating Symptoms of Diabetes
    Shu-Ming Huang, Cheng-Hung Chuang, Christine Joyce F. Rejano, Lemmuel L. Tayo, Cheng-Yang Hsieh, Steven Kuan-Hua Huang, Po-Wei Tsai
    Molecules.2023; 28(21): 7255.     CrossRef
  • Variability, Mean, and Baseline Values of Metabolic Parameters in Predicting Risk of Type 2 Diabetes
    Duong Duc Pham, Jaekyung Song, Yunwan Jeon, Ibrahimi Hajar, Chae Hun Leem
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): 1270.     CrossRef
  • Lipid Variability and Diabetes Mellitus
    Jeongmin Lee, Seung-Hwan Lee
    The Journal of Korean Diabetes.2022; 23(1): 28.     CrossRef
  • The Risk of Type 2 Diabetes Mellitus in a Russian Population Cohort According to Data from the HAPIEE Project
    Svetlana V. Mustafina, Oksana D. Rymar, Liliya V. Shcherbakova, Evgeniy G. Verevkin, Hynek Pikhart, Olga V. Sazonova, Yuliya I. Ragino, Galina I. Simonova, Martin Bobak, Sofia K. Malyutina, Mikhail I. Voevoda
    Journal of Personalized Medicine.2021; 11(2): 119.     CrossRef
  • The influence of VDR polymorphisms on the type 2 diabetes susceptibility in Chinese: an interaction with hypertriglyceridemia
    Dongdong Zhang, Cheng Cheng, Yan Wang, Yuan Xue, Yaping Liu, Yiming Liu, Mingming Feng, Ze Xu, Wenjie Li, Xing Li
    Molecular Genetics and Genomics.2021; 296(4): 837.     CrossRef
  • Development and validation of a new diabetes index for the risk classification of present and new-onset diabetes: multicohort study
    Shinje Moon, Ji-Yong Jang, Yumin Kim, Chang-Myung Oh
    Scientific Reports.2021;[Epub]     CrossRef
  • Hypertriglyceridemia as an Independent Predictor for Ten-Year Incidence of Diabetes in Thais
    Suranut Charoensri, Supatida Turnsaket, Chatlert Pongchaiyakul
    Vascular Health and Risk Management.2021; Volume 17: 519.     CrossRef
  • Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
    Eun-Jung Rhee
    Endocrinology and Metabolism.2020; 35(1): 85.     CrossRef
  • HDL-Cholesterol, Its Variability, and the Risk of Diabetes: A Nationwide Population-Based Study
    Seung-Hwan Lee, Hun-Sung Kim, Yong-Moon Park, Hyuk-Sang Kwon, Kun-Ho Yoon, Kyungdo Han, Mee Kyoung Kim
    The Journal of Clinical Endocrinology & Metabolism.2019; 104(11): 5633.     CrossRef
  • Response: The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
    Eun-Jung Rhee, Yu Hyun Kwon
    Endocrinology and Metabolism.2018; 33(3): 425.     CrossRef
  • The Association between Persistent Hypertriglyceridemia and the Risk of Diabetes Development: The Kangbuk Samsung Health Study (Endocrinol Metab 2018;33:55–61, Yu Hyun Kwon et al.)
    Mi Hae Seo
    Endocrinology and Metabolism.2018; 33(2): 305.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP